General description
A highly potent antagonist slightly selective for NR2A over other subtype NMDA receptors (Ki = 0.041, 0.27, 0.63 and 1.99 µM for NMDA subtypes NR2A, NR2B, NR2C, and NR2D, respectively). Commonly used for various research in brain functions and disorders that neurotransmissions via NMDA receptors are involved.
Biochem/physiol Actions
Primary Target
NMDA receptors
Target Ki: 0.041, 0.27, 0.63 and 1.99 →M for NMDA subtypes NR2A, NR2B, NR2C, and NR2D, respectively.
Warning
Toxicity: Standard Handling (A)
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Murphy, R., et al. 2012. Psychopharmacol.219, 401.
Paoletti, P., et al. 2007. Curr. Opin. Pharmacol.7, 47.
Feng, B., et al. 2004. Br. J. Pharmacol.141, 508.
Lowe, A., et al. 1990. Neurosci. Lett.113, 315.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
- UPC:
- 42192201
- Condition:
- New
- HazmatClass:
- No
- MPN:
- 5048390001
- CAS:
- 126453-07-4
akash.verma@cenmed.com
(732) 447-1115





